UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 353

Sortiert nach

Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine

Scientific reports, 2018-04, Vol.8 (1), p.6483-13, Article 6483

2018

Volltextzugriff (PDF)

Metabolic studies with promagnon, methylclostebol and methasterone in the uPA +/+-SCID chimeric mice

The Journal of steroid biochemistry and molecular biology, 2011-11, Vol.127 (3), p.374-381

2011

Volltextzugriff (PDF)

Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line

Journal of general virology, 2016-08, Vol.97 (8), p.1865-1876

2016

Volltextzugriff (PDF)

Effect of hepatitis E virus infection on the human hepatic innate immune response in human liver chimeric mice

Journal of hepatology, 2017, Vol.66 (1), p.S246-S246

2017

Volltextzugriff (PDF)

Thermostability of seven hepatitis C virus genotypes in vitro and in vivo

Journal of viral hepatitis, 2013-07, Vol.20 (7), p.478-485

2013

Volltextzugriff (PDF)

G09 : Targeting a host-cell entry factor barricades antiviral resistant HCV variants from on-therapy breakthrough in human-liver mice

Journal of hepatology, 2015-04, Vol.62, p.S214-S214

2015

Volltextzugriff (PDF)

A simple and rapid method to determine the zygosity of uPA-transgenic SCID mice

Biochemical and biophysical research communications, 2003-08, Vol.308 (2), p.375-378

2003

Volltextzugriff (PDF)

P0674 : Clinically approved T-type calcium channel inhibitors prevent hepatitis C virus (HCV) membrane fusion in a genotype-dependent manner

Journal of hepatology, 2015-04, Vol.62, p.S574-S575

2015

Volltextzugriff (PDF)

P0676 : Clearance of persistent hepatitis c virus infection using a monoclonal antibody specific for tight junction protein claudin-1

Journal of hepatology, 2015-04, Vol.62, p.S575-S575

2015

Volltextzugriff (PDF)

O52 APOLIPOPROTEIN E MEDIATES HCV ESCAPE FROM HOST NEUTRALIZING ANTIBODIES

Journal of hepatology, 2014-04, Vol.60 (1), p.S21-S21

2014

Volltextzugriff (PDF)

1162 TURMERIC CURCUMIN INHIBITS ENTRY OF ALL HEPATITIS C VIRUS GENOTYPES INTO HUMAN LIVER CELLS

Journal of hepatology, 2013-04, Vol.58, p.S473-S473

2013

Volltextzugriff (PDF)

861 THE LECTIN GRIFFITHSIN HAS ANTIVIRAL ACTIVITY AGAINST HEPATITIS C VIRUS IN VITRO AND IN VIVO

Journal of hepatology, 2012-04, Vol.56, p.S335-S336

2012

Volltextzugriff (PDF)

827 EXPERIMENTAL HCV VACCINE COMBINING ADENOVIRUS AND PROTEIN ELICITS POTENT T-CELL RESPONSES AND NEUTRALIZING ANTIBODIES IN RODENTS

Journal of hepatology, 2012-04, Vol.56, p.S323-S323

2012

Volltextzugriff (PDF)

The interferon gamma secretion assay: a reliable tool to study interferon gamma production at the single cell level

Journal of immunological methods, 2004-03, Vol.286 (1), p.167-185

2004

Volltextzugriff (PDF)

Minimization of transmission errors in highly loaded plastic gear trains

Proceedings of the Institution of Mechanical Engineers. Part C, Journal of mechanical engineering science, 2007-09, Vol.221 (9), p.1117-1129

2007

Volltextzugriff (PDF)

P131 STAT transcriptional activity is controlled by regulated deacetylation

Cytokine (Philadelphia, Pa.), 2012-09, Vol.59 (3), p.561-561

2012

Volltextzugriff (PDF)

Blocking Entry of Hepatitis B and D Viruses to Hepatocytes as a Novel Immunotherapy for Treating Chronic Infections

The Journal of infectious diseases, 2021-01, Vol.223 (1), p.128-138

2021

Volltextzugriff (PDF)

Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections

Gut, 2023-06, Vol.72 (6), p.1186

2023

Volltextzugriff (PDF)

Development and validation of a quantitative gas chromatography–mass spectrometry method for the detection of endogenous androgens in mouse urine

Journal of Chromatography A, 2008-01, Vol.1178 (1), p.223-230

2008

Volltextzugriff (PDF)

101 HUMAN MONOCLONAL ANTIBODIES TARGETING SR-BI PREVENT HCV ENTRY AND VIRAL SPREAD IN VIVO

Journal of hepatology, 2011-03, Vol.54, p.S45-S45

2011

Volltextzugriff (PDF)

The human liver-uPA-SCID mouse: A model for the evaluation of antiviral compounds against HBV and HCV

Antiviral research, 2008-12, Vol.80 (3), p.231-238

2008

Volltextzugriff (PDF)

Cell Culture-Grown Hepatitis C Virus Is Infectious in vivo and Can Be Recultured in vitro

Proceedings of the National Academy of Sciences - PNAS, 2006-03, Vol.103 (10), p.3805-3809

2006

Volltextzugriff (PDF)

Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera

Hepatology (Baltimore, Md.), 2005-04, Vol.41 (4), p.847-856

2005

Volltextzugriff (PDF)

Heterologous prime-boost immunotherapy circumvents tolerance and induces broadly neutralizing antibodies that protects against hepatitis B and D co-infection and hepatitis D super-infection

JOURNAL OF HEPATOLOGY, 2022, Vol.77, p.S860

2022

Volltextzugriff (PDF)

1 – 25 von 353

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(319)
Mit Volltextzugriff
(283)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(210)
Life Sciences & Biomedicine
(188)
Humans
(176)
Biological And Medical Sciences
(101)
Medical Sciences
(90)
Male
(85)
Female
(82)
Animals
(56)
Middle Aged
(54)
Adult
(53)
Aged
(44)
Urology & Nephrology
(33)
Gynecology. Andrology. Obstetrics
(28)
Obstetrics & Gynecology
(28)
Mice
(26)
Reproductive Biology
(25)
Endometriosis
(22)
Non Tumoral Diseases
(20)
Pharmacology. Drug Treatments
(20)
Fundamental And Applied Biological Sciences. Psychology
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine

Metabolic studies with promagnon, methylclostebol and methasterone in the uPA +/+-SCID chimeric mice

Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line

Effect of hepatitis E virus infection on the human hepatic innate immune response in human liver chimeric mice

Thermostability of seven hepatitis C virus genotypes in vitro and in vivo

G09 : Targeting a host-cell entry factor barricades antiviral resistant HCV variants from on-therapy breakthrough in human-liver mice

A simple and rapid method to determine the zygosity of uPA-transgenic SCID mice

P0674 : Clinically approved T-type calcium channel inhibitors prevent hepatitis C virus (HCV) membrane fusion in a genotype-dependent manner

P0676 : Clearance of persistent hepatitis c virus infection using a monoclonal antibody specific for tight junction protein claudin-1

O52 APOLIPOPROTEIN E MEDIATES HCV ESCAPE FROM HOST NEUTRALIZING ANTIBODIES

1162 TURMERIC CURCUMIN INHIBITS ENTRY OF ALL HEPATITIS C VIRUS GENOTYPES INTO HUMAN LIVER CELLS

861 THE LECTIN GRIFFITHSIN HAS ANTIVIRAL ACTIVITY AGAINST HEPATITIS C VIRUS IN VITRO AND IN VIVO

Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody

827 EXPERIMENTAL HCV VACCINE COMBINING ADENOVIRUS AND PROTEIN ELICITS POTENT T-CELL RESPONSES AND NEUTRALIZING ANTIBODIES IN RODENTS

The interferon gamma secretion assay: a reliable tool to study interferon gamma production at the single cell level

Minimization of transmission errors in highly loaded plastic gear trains

P131 STAT transcriptional activity is controlled by regulated deacetylation

Blocking Entry of Hepatitis B and D Viruses to Hepatocytes as a Novel Immunotherapy for Treating Chronic Infections

Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections

Development and validation of a quantitative gas chromatography–mass spectrometry method for the detection of endogenous androgens in mouse urine

101 HUMAN MONOCLONAL ANTIBODIES TARGETING SR-BI PREVENT HCV ENTRY AND VIRAL SPREAD IN VIVO

The human liver-uPA-SCID mouse: A model for the evaluation of antiviral compounds against HBV and HCV

Cell Culture-Grown Hepatitis C Virus Is Infectious in vivo and Can Be Recultured in vitro

Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera

Heterologous prime-boost immunotherapy circumvents tolerance and induces broadly neutralizing antibodies that protects against hepatitis B and D co-infection and hepatitis D super-infection

Suchergebnisse filtern